Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
10.5 mg budesonide effervescent tablet for orodispersible use
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
21 mg budesonide effervescent tablet for orodispersible use
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
31mg budesonide effervescent tablet for orodispersible use
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
42mg budesonide effervescent tablet for orodispersible use
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
5Budesonide
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[9] 66, 93, 94, 95, 96, 97, 98, 228, 299 💬
6Budesonide ( Zentacort Capsules 3mg )
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 96 💬
7Budesonide (6 mg)
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
8Budesonide (9 mg)
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
9Budesonide 0.5 mg compresse orodispersibili
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
10Budesonide 0.5 mg orodispersible tablets
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
11Budesonide 0.5mg orodispersible tablet twice daily
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
12Budesonide 1 mg compresse orodispersibili
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
13Budesonide 1 mg orodispersible tablets
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
14Budesonide 1 mg orodispersible tablets (BUL 1 mg)
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
15Budesonide 1mg orodispersible tablet twice daily
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
16Budesonide 2 mg orodispersible tablets (BUL 2 mg)
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
17Budesonide 6 mg prolonged-release capsule, hard (BUX-PVII prototype)
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
18Budesonide 6 mg prolonged-release capsules, hard (BUX-PVII prototype)
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
19Budesonide 9 mg capsules, hard (BUX-PV)
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
20Budesonide 9 mg prolonged-release capsule, hard (BUX-PVII prototype)
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
21Budesonide 9 mg prolonged-release capsules, hard (BUX-PVII prototype)
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
22Budesonide [0.4mg/ml] viscous suspension
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
23Budesonide Gel
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
24Budesonide MMX
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
25Budesonide MMX 6 mg Tablet
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
26Budesonide MMX®
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
27Budesonide MMX® 6 mg
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
28Budesonide MMX® 9 mg
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
29Budesonide oral suspension
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
30Budesonide oral suspension [0.2 mg/ml]
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
31Budesonide Orodispersible Tablets (Jorveza)
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
32Budesonide plus Prevacid
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
33Budesonide-formoterol single inhaler
(D00246)		[2] Budesonide,
Formoterol		[2] Budesonide (D00246),
Formoterol 💬 		[2] ADRB2,
NR3C1 💬 		[9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 299 💬
34Budesonide-MMX
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
35Budesonide-MMX®
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
36Budesonide-MMX® 6 mg
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
37Budesonide-MMX® 9 mg
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
38Budesonide-MMX™
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
39Budesonide/formoterol
(D00246)		[2] Budesonide,
Formoterol		[2] Budesonide (D00246),
Formoterol 💬 		[2] ADRB2,
NR3C1 💬 		[9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 228 💬
40Combination Oral Budesonide and Rectal Hydrocortisone
(D00246)		[2] Budesonide,
Hydrocortisone		[2] Hydrocortisone ,
Budesonide (D00246) 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
41Compressa effervescente 0,5 mg di budesonide per uso orodispersibile
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
42Compressa effervescente 1 mg di budesonide per uso orodispersibile
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
43Formoterol/Budesonide
(D00246)		[2] Budesonide,
Formoterol		[2] Budesonide (D00246),
Formoterol 💬 		[2] ADRB2,
NR3C1 💬 		[9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 228 💬
44High Dose Budesonide
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
45High dose budesonide suspension
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
46High dose budesonide tablet
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
47High dose of budesonide
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 299 💬
48Inhaled/swallowed budesonide
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
49Low Dose Budesonide
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
50Low dose budesonide tablet
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
51Methylprednisolone or budesonide
(D00246)		[2] Budesonide,
Methylprednisolone		[2] Budesonide (D00246),
Methylprednisolone 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 96 💬
52Oral Budesonide
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
53Oral Budesonide Suspension (MB-9)
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
54Oral Budesonide Suspension (OBS)
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
55Oral Viscous Budesonide
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
56Oral Viscous Budesonide (OVB)
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
57Viscous/swallowed budesonide
(D00246)		[1] Budesonide[1] Budesonide (D00246) 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬